POL-P3b could inhibit the growth of cervical carcinoma by oral administration and the mechanism was related to inducing protection against tumor-induced intestinal DC apoptosis through stimulating the TLR4/PI3K/AKT-NF-κB signaling pathway. Here, TLR4 is linked to neoplasm.